Cargando…
A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Masson SAS.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362790/ https://www.ncbi.nlm.nih.gov/pubmed/32759053 http://dx.doi.org/10.1016/j.resmer.2020.100780 |
| _version_ | 1783559557962792960 |
|---|---|
| author | Joumaa, H. Regard, L. Carlier, N. Chassagnon, G. Alabadan, E. Canouï, E. L’honneur, A. Rozenberg, F. Burgel, P.-R. Roche, N. |
| author_facet | Joumaa, H. Regard, L. Carlier, N. Chassagnon, G. Alabadan, E. Canouï, E. L’honneur, A. Rozenberg, F. Burgel, P.-R. Roche, N. |
| author_sort | Joumaa, H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7362790 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73627902020-07-16 A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir Joumaa, H. Regard, L. Carlier, N. Chassagnon, G. Alabadan, E. Canouï, E. L’honneur, A. Rozenberg, F. Burgel, P.-R. Roche, N. Respir Med Res Letter to the Editor Published by Elsevier Masson SAS. 2020-11 2020-07-15 /pmc/articles/PMC7362790/ /pubmed/32759053 http://dx.doi.org/10.1016/j.resmer.2020.100780 Text en © 2020 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Joumaa, H. Regard, L. Carlier, N. Chassagnon, G. Alabadan, E. Canouï, E. L’honneur, A. Rozenberg, F. Burgel, P.-R. Roche, N. A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir |
| title | A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir |
| title_full | A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir |
| title_fullStr | A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir |
| title_full_unstemmed | A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir |
| title_short | A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir |
| title_sort | severe covid-19 despite ongoing treatment with lopinavir-ritonavir |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362790/ https://www.ncbi.nlm.nih.gov/pubmed/32759053 http://dx.doi.org/10.1016/j.resmer.2020.100780 |
| work_keys_str_mv | AT joumaah aseverecovid19despiteongoingtreatmentwithlopinavirritonavir AT regardl aseverecovid19despiteongoingtreatmentwithlopinavirritonavir AT carliern aseverecovid19despiteongoingtreatmentwithlopinavirritonavir AT chassagnong aseverecovid19despiteongoingtreatmentwithlopinavirritonavir AT alabadane aseverecovid19despiteongoingtreatmentwithlopinavirritonavir AT canouie aseverecovid19despiteongoingtreatmentwithlopinavirritonavir AT lhonneura aseverecovid19despiteongoingtreatmentwithlopinavirritonavir AT rozenbergf aseverecovid19despiteongoingtreatmentwithlopinavirritonavir AT burgelpr aseverecovid19despiteongoingtreatmentwithlopinavirritonavir AT rochen aseverecovid19despiteongoingtreatmentwithlopinavirritonavir AT joumaah severecovid19despiteongoingtreatmentwithlopinavirritonavir AT regardl severecovid19despiteongoingtreatmentwithlopinavirritonavir AT carliern severecovid19despiteongoingtreatmentwithlopinavirritonavir AT chassagnong severecovid19despiteongoingtreatmentwithlopinavirritonavir AT alabadane severecovid19despiteongoingtreatmentwithlopinavirritonavir AT canouie severecovid19despiteongoingtreatmentwithlopinavirritonavir AT lhonneura severecovid19despiteongoingtreatmentwithlopinavirritonavir AT rozenbergf severecovid19despiteongoingtreatmentwithlopinavirritonavir AT burgelpr severecovid19despiteongoingtreatmentwithlopinavirritonavir AT rochen severecovid19despiteongoingtreatmentwithlopinavirritonavir |